Tinidazole: Potent Antimicrobial Treatment for Parasitic and Bacterial Infections
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.86 | $51.34 (0%) | 🛒 Add to cart |
| 90 | $0.82 | $77.02 $73.49 (5%) | 🛒 Add to cart |
| 120 | $0.79 | $102.69 $94.64 (8%) | 🛒 Add to cart |
| 180 | $0.77 | $154.03 $137.93 (10%) | 🛒 Add to cart |
| 270 | $0.76 | $231.05 $204.37 (12%) | 🛒 Add to cart |
| 360 | $0.75
Best per pill | $308.07 $268.80 (13%) | 🛒 Add to cart |
Synonyms
| |||
Tinidazole is a second-generation nitroimidazole antimicrobial agent prescribed for the treatment of various anaerobic bacterial and protozoal infections. It demonstrates high bioavailability, a prolonged half-life, and broad-spectrum activity against susceptible pathogens. This medication is particularly valued in clinical practice for its efficacy in managing giardiasis, amebiasis, trichomoniasis, and certain anaerobic bacterial infections. Proper usage under medical supervision ensures optimal therapeutic outcomes while minimizing risks.
Features
- Chemical class: Nitroimidazole antimicrobial
- Available forms: Oral tablets (250 mg, 500 mg)
- Mechanism of action: Disruption of DNA synthesis and helical structure in susceptible microorganisms
- Half-life: Approximately 12–14 hours
- Administration: Oral route, with or without food
- Prescription status: Requires medical prescription
Benefits
- Effective against a broad spectrum of anaerobic bacteria and protozoa
- Convenient once- or twice-daily dosing regimen due to extended half-life
- High oral bioavailability ensures reliable systemic absorption
- Demonstrated clinical efficacy in eradicating target pathogens
- Well-established safety profile when used as directed
- May reduce treatment duration compared to some alternative therapies
Common use
Tinidazole is indicated for the treatment of intestinal amebiasis (amebic dysentery), extraintestinal amebiasis (including amebic liver abscess), giardiasis (Giardia lamblia infections), and trichomoniasis caused by Trichomonas vaginalis. It is also used for the management of anaerobic bacterial infections, such as those caused by Bacteroides species, Clostridium species, and anaerobic streptococci. Off-label uses may include treatment of bacterial vaginosis and Helicobacter pylori eradication as part of combination therapy, though these are not universally approved indications.
Dosage and direction
Dosage varies based on infection type, patient age, and renal/hepatic function. For adults: Amebiasis—2 g once daily for 3 days; Giardiasis—2 g single dose; Trichomoniasis—2 g single dose or 1 g twice daily for 1 day; Anaerobic bacterial infections—2 g initial dose, then 1 g once daily for 5–6 days. Take with food to minimize gastrointestinal upset. Complete the full course even if symptoms improve earlier. Do not crush or chew tablets; swallow whole with water.
Precautions
Use with caution in patients with central or peripheral nervous system disorders, blood dyscrasias, or hepatic impairment. Avoid alcohol consumption during treatment and for at least 3 days after completion due to risk of disulfiram-like reaction. May cause dizziness or drowsiness; caution when operating machinery or driving. Not recommended during first trimester of pregnancy; use in later trimesters only if clearly needed. Monitor for signs of superinfection or fungal overgrowth.
Contraindications
Hypersensitivity to tinidazole, other nitroimidazole derivatives, or any component of the formulation. Contraindicated in patients with organic neurological disorders. Avoid use during first trimester of pregnancy. Not recommended for nursing mothers due to secretion in breast milk. Do not administer to patients with history of blood dyscrasias. Contraindicated in combination with disulfiram or within 2 weeks of disulfiram therapy.
Possible side effect
Common: Nausea, metallic taste, anorexia, vomiting, diarrhea, dizziness, headache. Less common: Fatigue, darkening of urine, peripheral neuropathy, seizures, ataxia, vertigo, skin rash, pruritus. Rare: Leukopenia, neutropenia, flushing, oral candidiasis, hepatitis, pancreatitis. Discontinue if severe neurological symptoms, hypersensitivity reactions, or abnormal blood counts occur.
Drug interaction
Potentiates effects of warfarin and other oral anticoagulants (monitor INR). Concurrent use with alcohol may cause disulfiram-like reaction. May increase plasma levels of phenytoin, lithium, and cyclosporine. Cimetidine may prolong tinidazole half-life. Inducers of CYP450 enzymes (e.g., phenobarbital, rifampin) may decrease tinidazole concentrations. Avoid concurrent administration with disulfiram. Use caution with other neurotoxic drugs.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to catch up. Resume the regular dosing schedule. If multiple doses are missed, contact a healthcare provider for guidance. Maintaining consistent blood levels is important for efficacy, especially in severe infections.
Overdose
Symptoms may include nausea, vomiting, dizziness, ataxia, and seizures. There is no specific antidote. Management is supportive and symptomatic: gastric lavage if recent ingestion, activated charcoal may be considered, and anticonvulsants for seizure control. Hemodialysis may enhance elimination. Contact poison control or seek emergency medical attention immediately.
Storage
Store at controlled room temperature (20–25°C or 68–77°F). Protect from light and moisture. Keep in original container with lid tightly closed. Do not store in bathroom or near sink. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Properly discard any unused medication.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Tinidazole is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Individual response to treatment may vary. Always follow your healthcare provider’s instructions regarding dosage, duration, and precautions. Report any adverse effects or concerns to your physician promptly.
Reviews
Clinical studies and meta-analyses consistently demonstrate tinidazole’s efficacy in treating protozoal infections, with cure rates often exceeding 90%. Physicians appreciate its convenient dosing schedule and generally favorable tolerability profile. Some patients report gastrointestinal side effects, though these are typically mild and self-limiting. The extended half-life is frequently cited as a significant advantage over metronidazole in certain clinical scenarios. Long-term safety data continue to support its appropriate use in indicated infections.